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Abstract
How can evidence from economic evaluations of the type the Disease Control Priorities project have synthesized 
be translated to better priority setting? This evidence provides insights into how investing in health, particularly 
though priority interventions and expanded access to health insurance and prepaid care, can not only save lives 
but also help alleviate poverty and provide financial risk protection. The article discusses some of the relevant 
factors needed to develop a Theory of Change for translating economic evidence to better priority setting 
within countries, and proposes some key strategic choices that are necessary to achieve the desired outputs and 
outcomes.
Keywords: Theory of Change, Priority Setting in Health, Economic Evaluation, Equity
Copyright: © 2018 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Citation: Norheim OF. Disease Control Priorities Third Edition is published: a theory of change is needed for 
translating evidence to health policy. Int J Health Policy Manag. 2018;7(9):771–777. doi:10.15171/ijhpm.2018.60
*Correspondence to:
Ole F. Norheim
Email: ole.norheim@uib.no
Article History:
Received: 1 March 2018
Accepted: 17 June 2018
ePublished: 30 June 2018
Editorial
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
http://ijhpm.com
Int J Health Policy Manag 2018, 7(9), 771–777 doi 10.15171/ijhpm.2018.60
The Disease Control Priorities project aims to promote and support the use of economic evaluation for priority setting at both global and national levels. The 
first edition, DCP1, was published by the World Bank in 1993, 
as a companion volume to the World Bank report “Investing 
in Health” commissioned by chief economist Larry Summer 
and written by a team that included a young doctor and health 
economist Chris Murray, with economist Dean Jamison 
as senior lead author.1,2 In a famous interview in The New 
Yorker, Bill Gates told the story of how Investing in Health 
influenced him on how to spend his wealth when moving into 
philanthropy.3 This small report has been hugely influential 
though international actors, also beyond the Bill and Melinda 
Gates Foundation.4 
The report provided a convincing analysis that investing in 
health could yield substantial economic returns. Healthcare 
is not only an expenditure for the ministries of finance. If 
resources are invested wisely, people will live longer and have 
more productive lives. Healthy children learn better, malaria 
prevention reduces absenteeism and increases productivity, 
and public finance protects against catastrophic health 
expenditures. 
A key message of DCP1 was that resource allocation within 
the health sector should aim at health maximization, and the 
tool to identify which interventions and policies to invest in is 
cost-effectiveness analysis. By modeling costs per disability-
adjusted life year (DALY) averted, the most efficient ranking 
of services can be determined. The report also proposed 
that countries should invest in an essential package of public 
health interventions and a package of essential clinical 
services that would yield the maximum health benefit.1 DCP2 
was published in 2006 with updated economic analyses and 
a more developed emphasis on service delivery platforms: at 
what level of the health system are policies and services most 
effective?5 
The recommendations from the Disease Control Priorities 
Project have also been met with considerable resistance and 
criticism. While the World Health Organization (WHO) and 
the World Bank early on championed cost-effectiveness as 
a key criterion for global and national resource allocation,2,6 
philosophers, ethicists and others in the social justice 
tradition have argued that this approach is insensitive to the 
distributional aspects of priority setting.7-9 Equity also matters. 
Other have discussed whether a reliance on cost-effectiveness 
alone is compatible with a human rights approach to health 
and healthcare.10 
Some even argued that all substantive values underlying 
priority setting, and especially cost-effectiveness, are so 
contested that they should be replaced by a fair and legitimate 
process.11 Others hold that both process and substantive 
judgments are important.7,8,12 The broader democratic 
processes include better governance for health and public 
participation. Governments and other relevant institutions 
can be held accountable for ensuring that proper participatory 
processes are in place.13,14 Yet, few countries have really 
succeeded in going beyond technocratic approaches to 
inclusive priority setting. The “political determinants” of 
health, barriers to global governance such as power structures 
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and unfair trade agreements, can also hamper change.15 
Health policy needs to go beyond cost-effectiveness, to set 
priorities with respect to the worse off (in terms of health and 
poverty) and financial risk protection – and though robust 
processes in each country.16
Disease Control Priorities, Third Edition
In December 2017, the ninth and final volume of DCP3 was 
published and launched in London.17,18 The volume, and its 
companion paper in the Lancet, summarizes recommended 
essential Universal Health Coverage (UHC) packages for low- 
and lower-middle-income countries for all areas of health: 
intersectoral policies, laws and regulations, financing, public 
health, as well as health services relating to surgery, cancer, 
noncommunicable diseases, injuries, mental health, adolescent 
health, reproductive, maternal and child health, and infectious 
diseases. These can be progressively implemented to speed 
up the move towards UHC as fulfilment of the Sustainable 
Development Goals for health (SDG3) and poverty (SDG1). 
Recognizing that the costs of such comprehensive packages 
would not, for some countries, find room within the fiscal 
space for health, DCP3 also recommends a highest priority 
package that could be implemented first, and at less cost.18 
Translating Evidence Into Better Priority Setting
DCP3 in many ways responds to earlier criticisms and widens 
the frame for discussion of health policies and priorities by 
addressing the different needs of countries at different stages 
in the development of their health systems. DCP3 also draws 
attention to equity and the catastrophically impoverishing 
effects that paying out of pocket for health services can have 
on poor families. This analysis, using data on private health 
expenditures, provides insights into how investing in health, 
particularly in expanded access to health insurance and 
prepaid care, can not only save lives but also help alleviate 
poverty and bolster financial security.
Several countries have expressed interest in using DCP3 
evidence for better priority setting, and concrete projects 
have been initiated in Ethiopia, Afghanistan, Iran, and other 
countries in the Eastern Mediterranean Region (WHO 
EMRO).19 The question is how this can best be done. A first 
step would be to formulate and discuss a Theory of Change. 
Towards a Theory of Change for Better National Priority 
Setting
To translate evidence into policy for better priority setting, a 
complex process in itself, several factors need to be in place, 
work together, and lead to the desired outcomes. Making 
explicit the underlying Theory of Change is one approach 
recommended to clarify what is needed for achieving goals 
of this type. Theory of Change was developed within the 
tradition of theory-driven evaluation. Many organizations 
have used Theory of Change to improve programme 
implementation.20 
Definitions of Theory of Change vary greatly. Breuer et al 
define Theory of Change as an approach which describes 
how a programme brings about specific long-term outcomes 
through a logical sequence of intermediate outcomes.20,21 
A Theory of Change is often developed using a backward 
mapping approach which starts with the long-, medium-, and 
short-term outcomes and then maps the required process of 
change. 
According to Vogel, the elements typically include outcomes, 
assumptions about what needs to be in place for change to 
occur, a description of contextual factors, beneficiaries, 
research evidence supporting the Theory of Change, actors 
in the context, their sphere of influence, strategic choices and 
interventions, timelines, and indicators.20 
In what follows I sketch and discuss some of the relevant 
factors needed to develop a Theory of Change for translating 
economic evidence of the type DCP has generated to better 
priority setting within countries. I do not aim to develop 
a full-fledged Theory of Change fit for this purpose, but 
rather start a debate on what we need to understand before 
embarking on such an endeavor.
First, we need to define what we mean by translating DCP 
evidence into better priority setting. The Disease Control 
Priorities Project aimed to promote and support the use of 
economic evaluation for priority setting at both global and 
national levels. In DCP3, the aim has been further clarified 
by including a concern for equity – fair distribution – and 
financial risk protection. In the next phase of DCP, more 
emphasis is needed at national levels. One definition of better 
priority setting within countries would include three goals: to 
improve population health, not only the average level of health 
but also its distribution, with financial protection. Since we 
are in the era of SDGs and UHC, we may even formulate the 
most ambitious long-term outcome of priority setting as “all 
people receiving essential quality health services that meet 
their needs without being exposed to financial hardship in 
paying for the services.”16,22
Better Priority Setting as a Long-term Outcome for Countries
Better national priority setting goes beyond what DCP can 
achieve. Yet, it is useful to describe a fair system in which 
economic evidence has a key role. A fair system for evidence-
based priority setting in the health sector would include the 
following three elements: (a) Clear priorities: a reasonably 
well defined essential package of essential health services or 
publicly available descriptions of high-priority services to 
which people are entitled and information about how these 
services are to be financed; (b) Publicity: the package or range 
of high priority services is known by policy makers, actors in 
the health system, and citizens; and (c) Institutionalization: the 
process of priority setting is institutionalized and supported 
by the political system, is open and transparent, protected by 
legal regulation, linked to financing mechanism, and enjoys 
reasonable public support. 
Clearly, such aims would be too ambitious and hard to 
measure by a set of indicators for a more modest Theory of 
Change. Figure summarises some elements of a Theory of 
Change for DCP country translation work. 
Long-term Country Outcomes for DCP
There are several of the above elements that go far beyond 
what a project such a DCP could achieve. I therefore propose 
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the following alternative, but not mutually exclusive long-
term outcomes:
– Use of DCP evidence in a defined essential health service 
package for 
a. the whole health system, or for
b. delivery platforms such as primary care, public health, or 
intersectoral programs, or for
c. programs such as reproductive, maternal, neonatal, and 
child health services, non-communicable diseases (NCDs) 
services, or emergency care, or
– Institutionalized priority setting: eg, establishment of a 
health financing and priority setting unit in Ministry of 
Health (MoH) or under MOH (such as in a national Public 
Health Institute), or 
– Establishment of a national health technology assessment 
(HTA) agency (under the MoH or independent from it).
Although creating institutions is the responsibility of 
countries, DCP could help and support institutionalizing 
priority setting. For some countries, these long-term outcomes 
could be achieved within a 5-year period, for others, the time 
horizon would be longer. 
Medium-term Country Outcomes for DCP
Realistic and medium-term outcomes for DCP country 
translation work could include the following: 
– Availability of national expertise within the health system 
that will understand, demand, access, use, and translate 
evidence relevant for priority setting, and
– Explicit and evidence-based priority setting as part of 
comprehensive strategic plans to achieve UHC, or
– Explicit and evidence-based priority setting as part of 
national plans for primary care, NCDs, injury prevention and 
treatment, emergency care, surgery, or essential drugs list, etc, 
or 
– Use of DCP evidence (and economic evaluations from other 
sources) by policy makers to make priority setting decisions. 
Options for Defining Short-term DCP Outputs
Short-term outputs that could be achieved, and that are 
preconditions for achieving the long-term outcomes, could 
include: (a) academic capacity in the country that can critically 
assess evidence, reports and recommendations and generate 
new country-relevant evidence if needed; (b) publications 
and reports on economic evaluation, priority interventions, 
essential packages, or guidance on process and criteria for 
priority setting; and (c) participation by key actors in public, 
political, or academic debates on priority setting. 
Preconditions for Better Priority Setting
What needs to be in place for the desired change to occur? In 
my view, at least five elements must be in place. First, there must 
be available timely, accurate and accessible evidence on costs 
and outcomes relevant for health systems strengthening, such 
as policy instruments, cross-sectoral public health actions, and 
clinical interventions tailored to delivery platforms or disease 
programs of relevance to governments and other actors that 
want to set priorities. Although incomplete, and not always 
contextualized to all national settings, DCP3 evidence is 
published and available, and is a good starting point for 
work on translation. More work needs to be done to make 
it even more available through an interactive web site with 
easily downloadable data and results. Evidence needs to be 
• DCP evidence
• Technical capacity
• Capacity strengthening
• Political will and firm commitment to change within country
Input
• Availability of national expertise within the health system that will understand, 
demand, access, use, and translate evidence relevant for priority setting
• Publications and reports on economic evaluations, priority interventions, essential 
packages, or guidance on process and criteria for priority setting
• Participation by key actors in public, political, or academic debates on priority setting
DCP short-
term output
• Academic capacity in the country that can critically assess evidence, reports and 
recommendations and generate new country-relevant evidence if needed
• Use of DCP evidence by policy makers
• Explicit and evidence-based priority setting as part of national plans for either: 
primary care, NCDs, injury prevention and treatment, emergency care, surgery, or 
essential drugs list
Intermediate 
country 
outcomes
- Use of DCP evidence in a defined essential health service package, and/or
- Institutionalized priority setting:
- A health financing and priority setting unit in or under MoH, or
- A national health technology assessment agency
Long-term 
country 
outcomes
Figure. Elements of a Theory of Change for DCP Country Translation Work. Abbreviations: DCP, Disease Control Priorities; NCDs, non-communicable 
diseases; MoH, Ministry of Health.
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more accessible and packaged in more user-friendly formats. 
Second, in each country that embarks on this process, there 
must be political will to initiate work on translating DCP 
evidence to policy. Such support should be available from 
the highest levels of the MoH, given the political nature of 
priority setting. Third, a minimum of interest, expertise and 
capacity for initiating work on translating DCP evidence into 
policy is necessary to start the process. This is more likely 
to be more true in lower-middle-income countries than in 
low-income countries, but most countries today have some 
expertise within the bureaucracy that could understand and 
initiate the process. Fourth, if national expertise is incomplete, 
there must be available technical support and capacity for 
training in the initial phase. In South East Asia, Thailand’s 
Health Intervention and Technology Assessment Program 
(HITAP), supported by the International Decision Support 
Initiative (iDSI), serves as a hub for providing such expertise 
to neighboring countries.23 DCP and WHO-CHOICE also 
provide such support.24 Finally, a program for translating 
evidence to policy in low-income countries and lower-
middle-income countries requires funding, from national 
sources and often from external sources as well. 
Contextual Factors
A careful assessment of contextual factors is also needed, 
although not all of the following can be influenced by projects 
such as DCP. Every country is special, and there are significant 
differences between low-income and lower-middle-income 
countries. Many of them are expanding their system towards 
the goal of UHC and have a unique opportunity to create new 
procedural mechanisms and institutions for better priority 
setting. 
Yet, with respect to the prospect of implementing better 
systems for priority setting, many of the countries face 
substantial challenges. All countries have scarce resources 
for health. Low-income countries often rely on substantial 
external funding and donors have extensive influence on 
national priorities. There are also in many countries few 
people with expertise to understand, demand, access, use, 
and translate evidence relevant for priority setting. Another 
obstacle may be lack of political will. Explicit, accountable 
priority setting is not always preferable to implicit rationing, 
as may be easily understood if we adopt a political economy 
perspective on the hard choices they face.25-27 Under extreme 
resource scarcity, priority setting is after all about life and 
death, about distributing benefits and burdens, about winners 
and losers. Responsible policy makers also face considerable 
pressure from political elites and a growing middle class with 
political voice and influence. Priorities made often reflect 
these kinds of political constraints. 
The professional organizations are often weak, with little 
influence on the professional direction and development 
of the health system. Another common characteristic is 
an unregulated private sector leading to overutilization, 
overpricing, and inefficiencies. Low salaries force many 
working in the public sector to also work elsewhere. Health 
systems are more often than not fragmented, mostly 
developed for providing basic prevention and health 
promotion and acute care for infectious diseases, child and 
maternal health. Low-income countries often rely on vertical 
programs that have proven efficient in earlier phases, but 
are ill equipped to handle growing needs for NCDs services. 
Lower-middle-income countries are in the midst of that 
transition toward integrated, comprehensive services for 
chronic conditions. 
As for planning and budgeting, there is often inertia, 
and budgeting processes are typically based on previous 
allocations that are hard to shift. Add to this complex health 
financing mechanisms with multiple sources of funding, 
high out of pocket expenditures and inadequate prepayment 
mechanisms.22 Better priority setting for which services 
should be included under public finance presuppose that a 
larger share of total health expenditures is shifted to pooled 
funds. Since there are often weak mechanisms for pooling of 
resources and collection of tax revenue, and limited health 
insurance (often only for select groups such as civil servants), 
decision-makers’ control of funds is much more limited 
than in single payer systems such as the National Health 
Service (NHS) in the United Kingdom or in the Nordic 
countries. Another real challenge is to reach and convince 
strong ministers and ministries of finance that they should 
invest in health. They may have limited interest in financing 
healthcare (especially where there is extensive external 
funding) compared to other pressing budget needs such as for 
education, poverty eradication and infrastructure. 
Academic institutions often lack the expertise to educate new 
professionals in relevant disciplines such as health economics, 
mathematical modelling, demography and population 
epidemiology (burden of disease), evidence-based medicine, 
HTA, health policy, health systems, health services research, 
and population-level bioethics. 
Evidence Supporting Assumptions Shaping the Theory of 
Change
Vogel and Breuer et al also recommend looking at evidence 
supporting the assumptions and contextual factors shaping 
the Theory of Change. I have looked at a few studies 
that identify challenges and pitfalls that are necessary to 
understand before attempts at improving priority setting 
decisions and processes.28-38 Several qualitative studies are of 
particular interest for understanding why there are barriers to 
implementing evidence from economic evaluations. 
A study from Thailand by Teerawattananon and Russell 
reports qualitative findings on policymakers’ perspectives 
on the acceptability of using economic evaluation for the 
development of health-care benefit packages in Thailand.31 
Among other findings, the study reported that policy actors 
thought that economic evaluations were relevant for decision-
making because of the increasing need for rationing and more 
transparent criteria for making UHC decisions. They also 
reported a range of other factors that influenced the inclusion 
or exclusion of interventions: number of patients that need 
to be treated, severity of disease, cost of interventions and 
affordability, equity of access, and coverage of similar services 
by other health insurance schemes. Moreover, respondents 
raised several difficulties with using economic evaluation that 
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would pose barriers to its introduction, including distrust in 
the methods used, lack of understanding of key outcomes 
reported (such as quality-adjusted life years [QALYs] gained 
and disability-adjusted life years [DALYs] averted), as well as 
conflicting philosophical positions and priorities compared 
to that of “health maximization.” Other criteria also thought 
to be relevant included severity of disease, social solidarity, 
and equity. The respondents also pointed to organizational 
allegiances, existing decision-making procedures that would 
be hard to change, and concerns about political pressure and 
acceptability. 
A small qualitative study by Jain et al on advancing HTA 
in India found that although there is a good understanding 
of HTA among key actors, and a positive perception about 
producing and using HTA for decision-making among all 
the stakeholders interviewed, there was lack of knowledge 
about the subject among policy-makers at the lower levels. 
Importantly, at the national level, institutions prefer to treat 
the use of HTA evidence with caution because the capacity 
for adopting evidence-based tools in the health system is very 
limited.39
In a study from more than ten years ago, Kapiriri and 
Bondy explored health practitioners’ and health planners’ 
information needs and seeking behaviour for decision-making 
in Uganda.40 They reported that most of the epidemiological 
information was available and of relatively good quality but 
there was lack of information about distribution of benefits, 
segregated demographic data, and social values. The most 
often used sources of information included discussions 
with colleagues, doctors’ statements, and text books. They 
concluded that health planners and practitioners lack some 
of the information relevant for decision-making. Although 
an old study, in my experience these findings also ring true 
for many places today. Transferability of evidence from 
one context to another is also a challenge that should not 
be underestimated.41 Decision-makers often emphasise 
contextualised studies with local data. 
In another survey of stakeholders’ values with respect to 
priority setting in Uganda, Kapiriri and Norheim found that 
respondents assign high weight to criteria such as severity of 
disease, benefit of the intervention, cost of the intervention, 
cost-effectiveness of the intervention, quality of the data on 
effectiveness, patient age, place of residence, lifestyle. They 
also emphasised the importance of providing equity of access 
to healthcare and being perceptive to the community’s views.42 
These results are similar to the findings from Thailand. 
In summary, in different countries, key actors report 
that capacity is low, access to information difficult, and 
understanding and knowledge about economic evaluation, 
HTA, and the methods used are limited. There are practical 
and political constraints, and there are local and national 
values that sometimes conflict with what is seen as a simplistic 
health maximizing view on what priority setting in health 
entails. 
That said, the contextual barriers can be overcome through 
sensitive responses to appropriate and relevant objections. Local 
values matter. Moreover, the indirect influence of evidence 
should not be underestimated. In the last two decades, we 
have seen unprecedented improvements in health outcomes, 
partly driven by general economic growth and development, 
but also, I believe, through clear priorities influenced by the 
Millennium Developments Goals and identification of cost-
effective interventions targeting infectious disease, child and 
maternal health among the poor. Here, DCP1 and DCP2 has 
also played a role, as well as international actors such as the 
WHO through WHO-CHOICE, the Global Fund and Gavi. 
Countries have made many of the right choices, and those are 
not incompatible with the messages based on evidence from 
the Disease Control Priorities project. 
Beneficiaries, Target Audience, Actors, and Sphere of 
Influence
The beneficiaries of better priority setting would be citizens 
and patients, particularly the least well off, but also health 
planners, academic institutions and external funders. Moving 
from a system of ad hoc decisions in a fragmented health 
sector towards more systematic, evidence based health 
priorities would benefit everyone. This would be, in my view, 
the underlying motivating factor and could guide strategic 
choices in a Theory of Change. 
The target audiences for translating DCP evidence to better 
policies would include health policy makers within and 
outside of the MoH, health professionals, the ministry of 
finance, patients and patient organizations, civil society 
and citizens. The actors in each country would be many 
of the same, such as politicians, MoH officials, public 
health institutes, regulatory bodies, associations of medical 
professions, universities, health professionals, and patient 
organizations, but also non-governmental organizations, 
international donors, and regional and national World 
Bank and WHO offices. Among these actors, the sphere of 
influence in many low-income countries and lower-middle-
income countries would be strongest for people working 
in the ministries, parliamentarians, health professions and 
especially doctors, and external funders. Those with weakest 
influence are probably patients, civil society, women, people 
living with stigma, and other disadvantaged groups. Among 
institutions, the MoH is often weaker than the ministry of 
finance when it comes to budgeting decisions. 
Timeline
In any Theory of Change, the chosen timeline is important. 
In the context of better priority setting for achieving the 
SDGs for health, and UHC in particular, the most appropriate 
timeline is the period up to 2030 – which is now little more 
than 10 years. Another possible timeline for countries that 
typically develop national strategic 5-year plans would be 
the time period leading up to completion of these plans. In 
my view, a 5-year horizon would be a minimum to achieve 
desired short- and perhaps long-term outputs and outcomes. 
Process Indicators
A Theory of Change also needs indicators for measuring 
success in achieving country led, improved priority setting in 
the context of UHC. Health outcomes, coverage indicators, 
and indicators of financial risk protections are highly relevant 
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for the final outcomes, but probably difficult to include as 
indicators in a Theory of Change for translating DCP evidence 
into policy as discussed here. Factors interact, and other 
determinants beyond what priority setting can influence will 
also affect outcomes. Process indicators may also be relevant 
and appropriate. Priority-setting processes are hard to measure 
quantitatively, but a set of qualitative indicators can be useful. 
The assumption is that careful priority setting is crucial for 
fair progressive realization of UHC. WHO’s Consultative 
Group on Equity and UHC proposed the following four sets 
of process indicators: 
•	 Publicly available descriptions of essential packages or 
identified high-priority services to which people are 
entitled and information about how these services are 
to be financed (with special emphasis on out-of-pocket 
payments);
•	 Establishment of an institution or entity within an 
institution (such as within the MoH) responsible for 
assessing and evaluating scientific evidence relevant for 
priority setting;
•	 Publicly available and well communicated criteria for 
priority setting;
•	 Establishment of decision-making bodies (such as a 
national priority setting commission that many northern 
European countries have established) that involve 
citizens and key stakeholders in priority setting and 
provide reasons for priority-setting decisions.16 
Since better priority setting is a responsibility for countries, 
not DCP, the above process indicators would go beyond what 
DCP should be measured by. I therefore suggest the following 
process indicators of achieved medium- and long-term 
outcomes: 
•	 Use of evidence such as that from DCP by policy makers 
to make priority setting decisions. 
•	 Use of evidence such as that from DCP and explicit 
priority setting in strategic plans to achieve UHC or as 
part of national plans for primary care, NCDs, injury 
prevention and treatment, emergency care, surgery, or 
essential drugs list. 
Tentative Conclusion: Strategic Choices for Translating 
DCP Evidence Into Better Priority Setting
Developing a Theory of Change for a given country would 
include many of the elements identified above, but would be 
more country specific, and relevant stakeholders should be 
included in the process of its development. In addition, when 
all the elements are identified, strategic choices have to made 
with respect to how best to secure what needs to be in place for 
change to occur, how to overcome barriers, and how to reach 
the defined short- and long-terms goals. I shall conclude by 
tentatively suggesting 10 strategic choices that could be part 
of a Theory of Change for better priority setting: 
1. Secure technical and political support for embarking 
on the process. Establish the value framework as is 
appropriate to the country in question. Goals are often 
available in previous national health policy documents, 
and will typically reflect values such as improving health, 
fair distribution (equity), financial risk protection, and 
others. 
2. Develop analytic, research, planning, and process capacity 
within the health policy bureaucracy and management as 
well as in academic institutions. This will enable people to 
understand, demand, access, use, and translate evidence 
relevant for priority setting. Developing this capacity 
will require long-term commitments from academic 
institutions. 
3. Make evidence easily accessible and bring it to countries. 
4. Explore methods and checklists for transferring evidence 
from one context to another. Prioritize collection of local 
data and contextualized analysis. 
5. Establish open, transparent processes – and if possible 
institutions or a standing commission – for developing 
country specific priority setting recommendations. 
6. Include user-participation (patient organizations, topic 
experts, and decision-makers) in all phases leading 
up to recommendations, including identification of 
policy choices, policy space, fiscal space, evidence gaps, 
evidence collection, analysis, and appraisal. 
7. Allow for open hearings around hard choices with key 
stakeholder and make the underlying rationale explicit 
and clear in a language that can be understood by 
everyone. 
8. Publish recommendations in the form of nationally 
relevant essential packages or lists of high priority 
services so they are or can be known by all policy makers, 
actors in the health system, patients and citizens. 
9. Measure key process indicators at a predefined point in 
time.
10. Evaluate and revise both outputs and process. 
11. The evidence generated by the Disease Control Project 
could help countries move towards UHC and help in 
achieving the SDGs for health, poverty reduction and 
equality. Yet, it is not enough to publish large volumes 
and papers in high impact journals. Now the real work 
must begin.
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